: A study assessing the prevalence of risk factors (hypertension, overweight, etc.) in patients with Myotonic Dystrophy Type 1 (DM1) . Gastroenterology :
: For further details, the Elexon P397 Modification Page provides the final modification reports and consultation history. 2. Medical and Scientific Research : A study assessing the prevalence of risk
A study on predicting the risk of intraepithelial neoplasia in patients with longstanding . Genetic Disorders : Medical and Scientific Research A study on predicting
Research on the effectiveness of the drug for inducing remission in Inflammatory Bowel Disease. The label "P397" is frequently used as a
: It was formally approved by the energy regulator, Ofgem , in October 2020 and implemented on October 12, 2020 .
The label "P397" is frequently used as a poster or abstract identifier at major medical conferences. Some of the most notable reports under this tag include:
Analysis of distinct blood protein profiles in patients with ileal and colonic ulcers.